What is Arymo ER 30mg ?
Arymo ER 30mg (morphine sulfate) extended-release tablets are an opioid agonist indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.
Do not attempt to chew, crush, or dissolve. Swallow whole.
Arymo ER 30mg (Morphine sulfate) extended-release tablets are for oral use and contain morphine sulfate, an opioid agonist.
Arymo ER 30mg (Morphine sulfate) contains the following inactive ingredients common to all strengths: polyethylene oxide 400,000, butylated hydroxytoluene, polyvinyl alcohol, polyethylene glycol 3350, talc, and titanium dioxide.
Arymo ER 30mg (Morphine sulfate) strengths describe the amount of morphine per tablet as the pentahydrated sulfate salt (morphine sulfate)
• Use with caution in patients who have difficulty in swallowing or have
underlying GI disorders that may predispose them to obstruction, such
as a small gastrointestinal lumen.
Initial dose in opioid-naïve and opioid non-tolerant patients is 15 mg
every 8 or 12 hours
• Dosage adjustment may be done every 1 to 2 days.
• Take one tablet at a time, with enough water to ensure complete
swallowing immediately after placing in the mouth